BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 33688188)

  • 21. Antimicrobial gelatin-based elastomer nanocomposite membrane loaded with ciprofloxacin and polymyxin B sulfate in halloysite nanotubes for wound dressing.
    Shi R; Niu Y; Gong M; Ye J; Tian W; Zhang L
    Mater Sci Eng C Mater Biol Appl; 2018 Jun; 87():128-138. PubMed ID: 29549942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifunctional nanocarrier based on clay nanotubes for efficient intracellular siRNA delivery and gene silencing.
    Wu H; Shi Y; Huang C; Zhang Y; Wu J; Shen H; Jia N
    J Biomater Appl; 2014 Apr; 28(8):1180-9. PubMed ID: 23985535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(L-lactide)/halloysite nanotube electrospun mats as dual-drug delivery systems and their therapeutic efficacy in infected full-thickness burns.
    Zhang X; Guo R; Xu J; Lan Y; Jiao Y; Zhou C; Zhao Y
    J Biomater Appl; 2015 Nov; 30(5):512-25. PubMed ID: 26138705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clay nanotubes as a novel multifunctional excipient for the development of directly compressible diclofenac potassium tablets in a SeDeM driven QbD environment.
    Ahmed FR; Shoaib MH; Yousuf RI; Ali T; Geckeler KE; Siddiqui F; Ahmed K; Qazi F
    Eur J Pharm Sci; 2019 May; 133():214-227. PubMed ID: 30951825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of Uptake Mechanisms of Halloysite Nanotubes in Different Cell Lines.
    Biddeci G; Spinelli G; Massaro M; Riela S; Bonaccorsi P; Barattucci A; Di Blasi F
    Int J Nanomedicine; 2021; 16():4755-4768. PubMed ID: 34285481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adsorption and release of ofloxacin from acid- and heat-treated halloysite.
    Wang Q; Zhang J; Zheng Y; Wang A
    Colloids Surf B Biointerfaces; 2014 Jan; 113():51-8. PubMed ID: 24060930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Composite microparticles of halloysite clay nanotubes bound by calcium carbonate.
    Jin Y; Yendluri R; Chen B; Wang J; Lvov Y
    J Colloid Interface Sci; 2016 Mar; 466():254-60. PubMed ID: 26745741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Halloysite nanotube-embedded microparticles for intestine-targeted co-delivery of biopharmaceuticals.
    Homayun B; Choi HJ
    Int J Pharm; 2020 Apr; 579():119152. PubMed ID: 32081802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of N-doped ZnO-loaded halloysite nanotubes catalysts with high solar-light photocatalytic activity.
    Cheng ZL; Sun W
    Water Sci Technol; 2015; 72(10):1817-23. PubMed ID: 26540544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective Antimicrobial Effects of Curcumin@Halloysite Nanoformulation: A Caenorhabditis elegans Study.
    Fakhrullina G; Khakimova E; Akhatova F; Lazzara G; Parisi F; Fakhrullin R
    ACS Appl Mater Interfaces; 2019 Jul; 11(26):23050-23064. PubMed ID: 31180643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of multifunctional PEG-graft-Halloysite Nanotubes for Controlled Drug Release, Tumor Cell Targeting, and Bio-imaging.
    Yamina AM; Fizir M; Itatahine A; He H; Dramou P
    Colloids Surf B Biointerfaces; 2018 Oct; 170():322-329. PubMed ID: 29936385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study on the adsorption of Neutral Red from aqueous solution onto halloysite nanotubes.
    Luo P; Zhao Y; Zhang B; Liu J; Yang Y; Liu J
    Water Res; 2010 Mar; 44(5):1489-97. PubMed ID: 20003999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chitosan/halloysite nanotubes microcomposites: A double header approach for sustained release of ciprofloxacin and its hemostatic effects.
    Arshad MS; Qaiser M; Mahmood K; Shoaib MH; Ameer N; Ramzan N; Hanif M; Abbas G
    Int J Biol Macromol; 2022 Jul; 212():314-323. PubMed ID: 35618085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel Encapsulated in Halloysite Clay Nanotubes for Intestinal and Intracellular Delivery.
    Yendluri R; Lvov Y; de Villiers MM; Vinokurov V; Naumenko E; Tarasova E; Fakhrullin R
    J Pharm Sci; 2017 Oct; 106(10):3131-3139. PubMed ID: 28600185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Halloysite nanotubes as tools to improve the actual challenge of fixed doses combinations in tuberculosis treatment.
    Carazo E; Sandri G; Cerezo P; Lanni C; Ferrari F; Bonferoni C; Viseras C; Aguzzi C
    J Biomed Mater Res A; 2019 Jul; 107(7):1513-1521. PubMed ID: 30821051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity.
    Riela S; Massaro M; Colletti CG; Bommarito A; Giordano C; Milioto S; Noto R; Poma P; Lazzara G
    Int J Pharm; 2014 Nov; 475(1-2):613-23. PubMed ID: 25223492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of Etched- and Functionalized-Halloysite/Meloxicam Hybrids: A Tool for Enhancing Drug Solubility and Dissolution Rate.
    Friuli V; Urru C; Ferrara C; Conti DM; Bruni G; Maggi L; Capsoni D
    Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of halloysite nanotubes on physical properties and cytocompatibility of alginate composite hydrogels.
    Huang B; Liu M; Long Z; Shen Y; Zhou C
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):303-310. PubMed ID: 27770895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of Acid Treatment on the Loading and Release Behavior of Halloysite with 2-Mercaptobenzothiazole.
    Xing X; Wang J; Li Q; Hu W
    J Nanosci Nanotechnol; 2019 Nov; 19(11):7178-7184. PubMed ID: 31039873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of halloysite clay nanotubes as a pharmaceutical excipient.
    Yendluri R; Otto DP; De Villiers MM; Vinokurov V; Lvov YM
    Int J Pharm; 2017 Apr; 521(1-2):267-273. PubMed ID: 28235623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.